PFE News and Press, Pfizer Inc.

Pfizer Inc. (NYSE: PFE) today announced topline results from the Phase 3 SigVie-002 study (previously known as Be6A Lung-01) evaluating sigvotatug vedotin, an investigational, potential first-in-class integrin beta-6 (IB6) directed antibody-drug conjugate (ADC). The study enrolled adults with loc...

2026-06-22 10:47:31 ET Biotech And AI Names Heating Up Fast and becoming Wall Street's Next Breakout Wave DENVER, Colo. ( 247marketnews.com ) -- Several emerging public companies are attracting attention as artificial intelligence, healthcare innovation, medical technology, ...

2026-06-22 10:33:59 ET At the end of April, I published an article , " Merck: Bullish Setup Into Q1 Earnings, " in which I initially aimed to present the factors that would lead Merck & Co., Inc. ( MRK ) to once again show strong numbers.... Read the full article o...

2026-06-22 08:18:50 ET Acquisitions can be a double-edged sword for companies, as they can quickly bolster revenue and growth opportunities but also add costs and inefficiencies. Healthcare giant Pfizer (NYSE: PFE) has been involved in numerous acquisitions in recent years as it has...

2026-06-21 21:35:00 ET Pfizer (NYSE: PFE) is deeply unloved, down more than 50% from its late 2021 high. The stock decline has driven the dividend yield up to a very high 6.8%, well above the pharmaceutical stock average of 1.6%. The company is facing headwinds, which are clearly wo...

2026-06-21 04:44:00 ET Is it possible to retire on $500,000? Yes, but it won't be easy. The median U.S. household income is $88,510, according to Motio Research. To make that much money with an initial investment of $500,000, you'd need an annual return of 17.7%. It's possible to reach ...

2026-06-20 17:35:00 ET Eli Lilly (NYSE: LLY) is basically hitting it out of the park right now. Sales of its industry-leading GLP-1 weight-loss drugs Mounjaro and Zepbound rose 125% and 80%, respectively, in the first quarter of 2026, driving a huge 56% sales gain for the drug giant...

2026-06-20 07:44:13 ET When I last looked at biopharma concern Rigel Pharmaceuticals, Inc. ( RIGL ) in November, the stock had just had a huge rally. I concluded that article that I would wait for a significant pullback in the shares before it merited investment.... ...

2026-06-18 19:29:09 ET Pfizer (NYSE:PFE) , a large-cap biopharmaceutical company focused on medicines, vaccines, and specialty therapeutics, closed at $25.21, down 2.74%. This morning's CFO transition announcement and succession review kept investors focused on 2026 guidance and lea...

2026-06-18 07:05:23 ET More on Pfizer Pfizer Inc. (PFE) Discusses New Phase IIb Data and Development Plans for Berobenatide GLP-1 Receptor Agonist in Obesity - Slideshow Pfizer: Why I'm Still Expecting A Massive Rebound Roche Vs. Pfizer: Obesity Week Presentations De...